Asia

Serums vaccine trials to restart with added riders

PUNE: Advanced human trials of the Oxford vaccine candidate have resumed in the country after the Drug Controller General of India gave an all-clear to Serum Institute of India to restart the process.
The SII is partnering with Oxford University to manufacture the vaccine called Covishield in India. Specialists at 17 trial sites in the country will now start phase 3 of the trials, which is set to test the vaccine on a large number of volunteers.
The trials were paused on September 11 soon after a volunteer at a trial site in the UK developed an adverse reaction. But the DCGI has applied certain conditions, such as additional precautions during screening, additional information to volunteers while seeking informed consent, and close monitoring for adverse events during followups. The top drug regulator said the SII will have to follow these fresh directives “scrupulously”. Adar Poonawalla, owner and CEO of SII, said DCGIs go-ahead will put the process “back on track”. “The trials have no safety issue and thats why the DCGI allowed us to restRead More – Source

[contf]
[contfnew]

times of india

[contfnewc]
[contfnewc]

Related Articles

Asia

Joshua Wong and fellow activists plead guilty in Hong Kong protests trial

bbc– Hong Kong democracy activist Joshua Wong and two fellow campaigners are...

Asia

Works worth Rs 1,559 cr completed in Bihar out of PM s package of Rs 1.25 lakh cr: Congress

PATNA: Congress general secretary Randeep Surjewala on Tuesday claimed that works worth...

Asia

Ex-Trump fundraiser pleads guilty to illicit lobbying on 1MDB, China

WASHINGTON: A former top fundraiser for President Donald Trump pleaded guilty Tuesday...

Asia

Covid: Delhi more “open” than Mumbai

NEW DELHI: With Unlock 5.0 underway from October 15, more businesses and...